Showing 20 of 126 recruiting trials for “acute-lymphoblastic-leukemia”
Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) With or Without Rituximab Plus Recombinant Erwinia Asparaginase (JZP458) for the Treatment of Newly Diagnosed Ph Negative B-Acute Lymphoblastic Leukemia or T Acute Lymphoblastic Leukemia
👨⚕️ Ryan D. Cassaday, MD, Fred Hutch/University of Washington Cancer Consortium📍 1 site📅 Started Apr 2026View details ↗
Transcutaneous Auricular Vagus Nerve Stimulation for Insomnia in Survivors of Childhood Acute Lymphoblastic Leukemia
👨⚕️ Justin E Tanner, PhD, St. Jude Children's Research Hospital📍 1 site📅 Started Mar 2026View details ↗
RecruitingNCT07422337 ↗
A Multi-site Study to Evaluate the Persistence of Protective Immunity to Routine Childhood Vaccinations in Participants With B-ALL/Ly Who Have Received Blinatumomab
👨⚕️ Lauren Appell, MD, Arkansas Children's Research Institute📍 2 sites📅 Started Jan 2026View details ↗
Clinical Trial of CMD63 Chimeric Antigen Receptor T-cell (CAR T-cell) in Children With Acute Lymphoblastic Leukemia (ALL)
👨⚕️ Kanhatai Chiengthong, MD, King Chulalongkorn Memorial Hospital📍 3 sites📅 Started Jan 2026View details ↗
Telematic Cognitive Training and Mindfulness in Pediatric Patients After CAR-T Cell Therapy, Single Hematopoietic Allogeneic Transplant or Chemotherapy
A Study of Subcutaneous Blinatumomab in Children With R/R and and MRD+ B-Cell Precursor Acute Lymphoblastic Leukemia
Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia
A Study of Fludarabine Dosing in Children and Young Adults With B-cell Acute Lymphoblastic Leukemia
👨⚕️ Kevin Curran, MD, Memorial Sloan Kettering Cancer Center📍 3 sites📅 Started Oct 2025View details ↗
Children's Laughter and Fun Yoga as Adjunctive Pain Relief Following Chemotherapy.
👨⚕️ Bahaa W Bou Dargham, MD, Beirut Arab University and Hammoud Hospital University Medical Center📍 1 site📅 Started Oct 2025View details ↗
A Study of CTD402 in T-ALL/LBL Patients
HEM-iSMART-B: Dasatinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies
Efficacy of Targeted Drugs Combined With Chemotherapy in the Treatment of T-ALL
👨⚕️ Qifa Liu, Nanfang Hospital, Southern Medical University📍 1 site📅 Started Oct 2025View details ↗
A Clinical Study Evaluating the Safety and Efficacy of GT801 Injection in Adult Patients With Relapsed/Refractory CD19-positive B-cell Hematologic Malignancies and Autoimmune Hemolytic Anemia
A Phase 2 Study to Evaluate Efficacy of Calaspargase Pegol-mknl and Decitabine Combined With Venetoclax in Pediatric, Adolescent, and Young Adult Patients With Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia (T-ALL) and T- Cell Lymphoblastic Lymphoma (T-LLy)
Effectiveness and Safety of Blinatumomab and Donor Lymphocyte Infusion in Maintenance Therapy After Allogeneic Hematopoietic Stem Cell Transplantation for High-risk Ph Negative B Cell Acute Lymphoblastic Leukemia
CD19 Chimeric Antigen Receptor (CAR) T Cells in Adults With Relapsed/Refractory CD19 Positive Acute Lymphoblastic Leukemia
CD19 CAR-T Cell Infusion as Consolidation Therapy in Adolescent and Adult Patients With Acute B-ALL Ineligible for Allogeneic HSCT: A Clinical Study
225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome
In VIVO CAR-T Therapy for Relapsed/Refractory Hematological Malignancies
👨⚕️ Wang Sanbin, MD, 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China📍 1 site📅 Started Jul 2025View details ↗
Allogeneic CMV-Specific CD19-CAR T Cells Plus CMV-MVA Triplex Vaccine After Matched Related Donor Hematopoietic Cell Transplant for the Treatment of Patients With High-Risk Acute Lymphoblastic Leukemia
Page 1 of 7Next →
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →